发明名称 Chemical compounds
摘要 The present invention relates to imidazopyridazine derivatives. More particularly, it relates to 4-(biphenyl-3-yl)-7H-imidazo[4,5-c]pyridazine derivatives of formula (I):; and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4 and R5 are as defined in the description. The imidazopyridazine derivatives of the present invention modulate the activity of the GABAA receptor. They are useful in the treatment of a number of conditions, including pain.
申请公布号 US8952008(B2) 申请公布日期 2015.02.10
申请号 US201314103960 申请日期 2013.12.12
申请人 Pfizer Limited 发明人 Omoto Kiyoyuki;Owen Robert McKenzie;Pryde David Cameron;Watson Christine Ann Louise;Takeuchi Mifune
分类号 A01N43/58;A61K31/495;C07D487/00 主分类号 A01N43/58
代理机构 代理人 Dixon J. Michael
主权项 1. A compound according to formula (I)wherein R1 is selected from (C1-C4)alkyl, (C3-C4)cycloalkyl, NH2, and NH(C1-C4)alkyl and R2 is H; or R1 and R2 together are —CH2—CH2— or —N(CH3)—CH2—; R3 is selected from H, F, CHF2, OCH3 and CN; R4 is selected from H, F, Cl, OH, OCH3 and CN; and R5 is selected from (C2-C4)alkyl, (C3-C5)cycloalkyl and methyl-substituted (C3-C5)cycloalkyl,or a pharmaceutically acceptable salt thereof.
地址 Sandwich GB